Western Health Advantage
Retevmo (selpercatinib)
Drugs for Cancer : Drugs for Cancer
  • Step Therapy: Diabetes Type 2: DPP4 + Combo:
    ST Single Generic

  • Step Therapy: ST_APPLIES
  • Quantity Limit: limit maximum 30 day(s) supply
  • Prior Authorization: CIDP: Immune Globulin:
    PA Applies Immune Thrombocytopenic Purpura (ITP):
    Documented Diagnosis: Yes
    Duration: 6 Month(s)

    Pemphigus Vulgaris, PID: Immune Globulin:
    Documented Diagnosis: Yes
    Duration: 6 Month(s)
    Reauthorization Required: Yes